2026 American Academy of Neurology Abstract Website

Disclosures for "From Onset to Remission: Predictors of Trajectory and Personalized Risk in a Large French Myasthenia Gravis Cohort"

Mrs. Faedo has nothing to disclose.
Dr. sarah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for johnson and jonhson. Dr. sarah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. sarah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx.
Dr. GENDRE has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson & Johnson. Dr. GENDRE has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Miss IKHETEAH has nothing to disclose.
Dr. dormeuil has nothing to disclose.
Dr. Perrain has nothing to disclose.
Dr. Severa has received research support from Généthon, UPEC.
Miss TAHIRI has received personal compensation for serving as an employee of Excelya.
Dr. GRAVIER has nothing to disclose.
Dr. NORDINE has nothing to disclose.
Dr. Plante-Bordeneuve has nothing to disclose.
Prof. Lefaucheur has nothing to disclose.
Alain Creange has nothing to disclose.
Prof. AUTHIER has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARGENX. Prof. AUTHIER has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. The institution of Prof. AUTHIER has received research support from Ministry of Health. The institution of Prof. AUTHIER has received research support from French agency for research. The institution of Prof. AUTHIER has received research support from National agency for research on AIDS and transmissible disease.
Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.